NDC 0143-9299 – Ganciclovir
Ganciclovir Sodium 50 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC0143-9299
Product details
- Brand name
- Ganciclovir
- Generic name
- Ganciclovir sodium
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA076222
- Marketed since
- June 17, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor; Nucleoside Analog Antiviral
Active ingredients
- Ganciclovir Sodium 50 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0143-9299-10 | 10 VIAL in 1 BOX (0143-9299-10) / 10 mL in 1 VIAL (0143-9299-01) | Jun 17, 2021 |
Recalls mentioning this NDC
- D-0090-2023 Jan 4, 2023 · Class II
Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.
Other Ganciclovir products
- 42023-173 Ganciclovir Sodium 500 mg/10mL · Injection, Powder, Lyophilized, For Solution · Endo USA, Inc.
- 63323-315 Ganciclovir Sodium 500 mg/10mL · Injection, Powder, Lyophilized, For Solution · Fresenius Kabi USA, LLC
- 70436-089 Ganciclovir Sodium 500 mg/10mL · Injection, Powder, Lyophilized, For Solution · Slate Run Pharmaceuticals, LLC
- 51817-171 Ganciclovir Sodium 500 mg/10mL · Injection, Solution · Pharmascience Inc.
- 25021-185 Ganciclovir Sodium 50 mg/mL · Injection, Solution · Sagent Pharmaceuticals